Search Results - "Zeng, Veronica"

698 PD-L1 targeted CD28 costimulatory bispecific antibodies enhance T cell activation in solid tumors by Zeng, Veronica, Moore, Gregory, Diaz, Juan, Bonzon, Christine, Avery, Kendra, Love, Ruschelle, Dragovich, Matthew, Rashid, Rumana, Leung, Irene, Hackett, Michael, Qi, Jing, Bakhit, Charles, Muchhal, Umesh, Barlow, Norman, Desjarlais, John, Hedvat, Michael

“…BackgroundT cells in the tumor microenvironment require T cell receptor (TCR) /major histocompatibility complex engagement and costimulatory receptor…”
Get full text

697 Tumor-targeted CD28 costimulatory bispecific antibodies enhance T cell activation in solid tumors by Hedvat, Michael, Zeng, Veronica, Diaz, Juan, Bonzon, Christine, Avery, Kendra, Rashid, Rumana, Leung, Irene, Bartlow, Norm, Bakhit, Charles, Dragovich, Matthew, Bogart, Liz, Muchhal, Umesh, Desjarlais, John, Moore, Gregory

“…BackgroundT cells in the tumor micro-environment require TCR/MHC engagement and co-stimulatory receptor engagement to achieve complete activation. Solid tumors…”
Get full text

Abstract 5654: Affinity tuned Xmab®2+1 anti-mesothelin x anti-CD3 bispecific antibody induces selective T cell-dependent cellular cytotoxicity of human ovarian cancer cells by Zeng, Veronica G., Faber, Matthew S., Bernett, Matthew J., Avery, Kendra N., Zeytounian, John L., Rashid, Rumana, Muchhal, Umesh S., Moore, Gregory L., Desjarlais, John R., Hedvat, Michael

“…Abstract Mesothelin (MSLN) is a tumor-associated antigen highly expressed in ovarian tumors. Current treatment options for ovarian cancer have only modest…”
Get full text

Abstract 1880: PDL1-targeted CD28 costimulatory bispecific antibodies enhance T cell activation in solid tumors by Moore, Gregory L., Zeng, Veronica, Diaz, Juan, Bonzon, Christine, Avery, Kendra N., Love, Ruschelle, Dragovich, Matthew, Rashid, Rumana, Hackett, Michael, Leung, Irene W., Qi, Jing, Bakhit, Charles G., Muchhal, Umesh S., Barlow, Norman J., Desjarlais, John R., Hedvat, Michael

“…Abstract T cells in the tumor micro-environment require TCR/MHC engagement and co-stimulatory receptor engagement to achieve complete activation. Tumor cells…”
Get full text

IFN-γ-deficient transplant induces acute gut GVHD via dysregulation of RagIIIγ and intestinal microbiota by Song, Qingxiao, zeng, Veronica, Wu, Xiwei, Riggs, Arthur D., Zeng, Defu

“…Abstract Gut GVHD is critical for determining the outcome of allogenic hematopoietic cell transplantation (HCT). Damage of Paneth cells, loss of defensins, and…”
Get full text

Abstract 5663: Affinity tuned XmAb®2+1 PSMA x CD3 bispecific antibodies demonstrate selective activity in prostate cancer models by Nisthal, Alex, Dragovich, Matthew, Pong, Erik W., Zeng, Veronica, Hedvat, Michael, Bonzon, Christine, Avery, Kendra, Rashid, Rumana, Ardila, Connie, Muchhal, Umesh S., Moore, Gregory L., Chu, Seung Y., Desjarlais, John R.

“…Abstract Bispecific antibodies enable therapeutic modalities inaccessible to traditional mAbs, such as T cell engagers that bind both CD3 on T cells and a…”
Get full text

Abstract 2983: Tumor-specific CD28 costimulatory bispecific antibodies enhance T cell activation in solid tumors by Dragovich, Matthew A., Davra, Viralkumar, Faber, Matthew S., Kim, Yoon Kyung, Nisthal, Alex, Zeng, Veronica G., Jacinto, Jonathan, Diaz, Juan E., Truong, Thuy, Qi, Jing, Avery, Kendra N., Rashid, Rumana, Lee, Sung-Hyung, Chu, Seung Y., Bonzon, Christine, Love, Ruschelle, Bernett, Matthew J., Ernst, James A., Bahjat, Rena, Barlow, Norman J., Desjarlais, John R., Hedvat, Michael, Moore, Gregory L.

“…Abstract T cells in the tumor micro-environment require TCR/MHC engagement and co-stimulatory receptor engagement to achieve optimal activation. Solid tumor…”
Get full text